Design Therapeutics, Inc. Common Stock (DSGN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DSGN. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 133 institutions reported holding DSGN, with 43.3 million shares worth $626.4 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| SR One Capital Management | 6,526,476 | $94M | UNCHANGED |
| Logos Global Management | 3,000,000 | $43M | INCREASED |
| Baker Bros. Advisors | 2,678,430 | $39M | INCREASED |
| Driehaus Capital Management | 2,661,115 | $39M | INCREASED |
| BlackRock | 2,660,024 | $38M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Design Therapeutics, Inc. Common Stock on SentiSense.